(Q35997644)

11 August 2017

1 reference

title

Hyperphosphatemia in renal failure. (English)

1 reference

11 August 2017

Eberhard Ritz

1

1 reference

11 August 2017

Marie-Luise Gross

series ordinal

2

1 reference

11 August 2017

publication date

1 January 2005

1 reference

11 August 2017

1 reference

11 August 2017

volume

23

1 reference

11 August 2017

issue

1

1 reference

11 August 2017

page(s)

6-9

1 reference

Vascular calcification in patients with end-stage renal disease

11 August 2017

cites work

1 reference

Vascular calcification: a stiff challenge for the nephrologist: does preventing bone disease cause arterial disease?

21 January 2018

1 reference

Cloning and characterization of FGF23 as a causative factor of tumor-induced osteomalacia

21 January 2018

1 reference

The phosphatonin pathway: new insights in phosphate homeostasis

21 January 2018

1 reference

Disorders of phosphate metabolism--pathomechanisms and management of hypophosphataemic disorders

21 January 2018

1 reference

Transgenic mice overexpressing human fibroblast growth factor 23 (R176Q) delineate a putative role for parathyroid hormone in renal phosphate wasting disorders

21 January 2018

1 reference

Circulating concentration of FGF-23 increases as renal function declines in patients with chronic kidney disease, but does not change in response to variation in phosphate intake in healthy volunteers

21 January 2018

1 reference

FGF-23 in patients with end-stage renal disease on hemodialysis

21 January 2018

1 reference

Pathophysiology of vascular calcification in chronic kidney disease

21 January 2018

1 reference

Phosphate regulation of vascular smooth muscle cell calcification

21 January 2018

1 reference

Regulation of cardiovascular calcification

21 January 2018

1 reference

Phosphate-induced vascular calcification: role of pyrophosphate and osteopontin

21 January 2018

1 reference

Association of low fetuin-A (AHSG) concentrations in serum with cardiovascular mortality in patients on dialysis: a cross-sectional study

21 January 2018

1 reference

Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients

21 January 2018

1 reference

A systematic review of sevelamer in ESRD and an analysis of its potential economic impact in Canada and the United States

21 January 2018

1 reference

Randomized, double-blind, placebo-controlled, dose-titration, phase III study assessing the efficacy and tolerability of lanthanum carbonate: a new phosphate binder for the treatment of hyperphosphatemia

21 January 2018

1 reference

Phosphate binders in uraemia: pharmacodynamics, pharmacoeconomics, pharmacoethics

21 January 2018

1 reference

Stabilized polynuclear iron hydroxide is an efficient oral phosphate binder in uraemic patients.

21 January 2018

1 reference

The serum protein α2–Heremans-Schmid glycoprotein/fetuin-A is a systemically acting inhibitor of ectopic calcification

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1159/000082004

1 reference

11 August 2017

1 reference